In the field of cancer treatment, the drug Gavreto represents a significant breakthrough. Specifically designed to treat advanced non-small cell lung cancer with certain genetic mutations, Gavreto is also effective against advanced or metastatic RET-positive medullary thyroid cancer. The drug was created for an incredibly precise effect on cancer cells, changing the understanding of targeted therapy drugs.
Active ingredient: Pralsetinib
60 Tab, 90 Tab, 120 Tab